Search / Trial NCT06234176

Impact of Psychomotor Therapy on the Quality of Life in Depression

Launched by CENTRE HOSPITALIER ESQUIROL · Jan 29, 2024

Trial Information

Current as of October 04, 2024

Not yet recruiting

Keywords

Psychomotor Therapy Quality Of Life Major Depressive Disorder Psychomotor Profile Sensory Processing

Description

Hypothesis is that personalised weekly psychomotor therapy for 3 months (period of remission of depression) has a positive influence on the quality of life over time of people with MDD by improving their clinical (anxiety/anhedonia/psychomotor impairment) and psychomotor symptoms. In this study, the investigators propose to compare the quality of life of two groups of participants: a group receiving one psychomotor therapy session per week in addition to the usual treatments for depression, and a group receiving the usual treatments for depression. The investigators will evaluate changes i...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Diagnosis of depressive episode according to DSM-5 criteria.
  • * HDRS \> 16
  • * Hospitalized or followed-up in one of the participating centers.
  • * Affiliated or beneficiary of a social security scheme.
  • * Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and before any examination required by the research).
  • Exclusion Criteria:
  • * Psychiatric comorbidity (non-tobacco addiction, eating disorders, bipolar disorder, obsessive-compulsive disorder, schizophrenia and related disorders)
  • * Sensory impairment or proven neurological pathology
  • * History of neurological brain damage (including stroke, tumor, trauma resulting in loss of consciousness lasting more than 10 minutes)
  • * Limited functional ability (difficulty in moving about, performing manual tasks or moving about)
  • * Inability to understand questionnaires and study information
  • * Inability to travel to the inclusion center (personal vehicle, public transport)
  • * Pregnant or breast-feeding women, on declaration
  • * Forced hospitalization, subjects under guardianship or trusteeship, lack of social protection

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Limoges, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0